BIOAGE LABS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$295M
↓-17.7% -$63Mvs FY2024
Total Liabilities
$23M
↓-34.9% -$12Mvs FY2024
Equity
$272M
↓-15.8% -$51Mvs FY2024
Cash
$189M
↓-46.7% -$165Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $295M | $358M |
| Current Assets | $287M | $357M |
| Cash | $189M | $354M |
| ST Investments | $92M | $0 |
| Receivables | $769K | $0 |
| Inventory | $0 | $0 |
| Other Current | $5M | $3M |
| Non-Current Assets | $8M | $1M |
| PPE | $963K | $591K |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $100K | $100K |
| Other Non-Current | $7M | $440K |
| Total Liab+Eq | $295M | $358M |
| Current Liab. | $20M | $28M |
| Accounts Payable | $3M | $2M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $6M | $8M |
| Other CL | $12M | $18M |
| Non-Current Liab. | $3M | $7M |
| Long-Term Debt | $0 | $3M |
| Other LT Liab. | $3M | $5M |
| Equity | $272M | $323M |
| Retained Earnings | $333M | $253M |
| Other Equity | $0 | $70M |
QuarterCharts · SEC EDGAR data · BIOA · Comparing FY2025 vs FY2024